Summit Global Investments’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$365K Buy
3,803
+249
+7% +$25.5K 0.02% 406
2026
Q1
$388K Hold
3,554
0.02% 376
2025
Q4
$288K Sell
3,554
-68
-2% -$5.85K 0.02% 420
2025
Q3
$317K Buy
+3,622
New +$323K 0.02% 388
2024
Q4
Sell
-6,192
Closed -$575K 598
2024
Q3
$575K Buy
6,192
+146
+2% +$12.7K 0.04% 346
2024
Q2
$497K Sell
6,046
-9,930
-62% -$730K 0.03% 350
2024
Q1
$1.06M Sell
15,976
-3,400
-18% -$210K 0.08% 200
2023
Q4
$1.1M Buy
19,376
+2,331
+14% +$122K 0.07% 220
2023
Q3
$929K Buy
17,045
+5,302
+45% +$314K 0.06% 238
2023
Q2
$790K Buy
+11,743
New +$716K 0.05% 268
2018
Q4
Sell
-21,820
Closed -$845K 291
2018
Q3
$845K Buy
21,820
+2,100
+11% +$75.7K 0.11% 151
2018
Q2
$660K Buy
19,720
+3,200
+19% +$114K 0.1% 184
2018
Q1
$599K Hold
16,520
0.1% 143
2017
Q4
$526K Buy
+16,520
New +$566K 0.08% 221
2017
Q3
Sell
-18,000
Closed -$562K 240
2017
Q2
$562K Buy
+18,000
New +$520K 0.17% 119

Other funds holding LMAT

Summit Global Investments's LMAT Position: Q2 2026 in Review

Summit Global Investments increased its LeMaitre Vascular (LMAT) stake by 7% in Q2 2026, buying an estimated $25.5K and bringing the position to 3,803 shares worth $365K. The position accounts for 0.02% of the portfolio, ranked #406.

Summit Global Investments first reported a position in LMAT in Q2 2017 and has held it in 15 quarters since. The position peaked at $1.1M in Q4 2023. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Summit Global Investments held 3,803 shares of LeMaitre Vascular worth $365K as of Q2 2026.
  • Summit Global Investments bought 249 LeMaitre Vascular shares in Q2 2026, an estimated $25.5K.
  • LeMaitre Vascular made up 0.02% of Summit Global Investments's portfolio in Q2 2026, its #406 holding.
  • Summit Global Investments first reported a position in LeMaitre Vascular in Q2 2017 and has held it in 15 quarters since.
  • Summit Global Investments's LeMaitre Vascular position peaked at $1.1M in Q4 2023.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.